Author:
Addamiano Maria Claudia,Joannes Camille,Fonquerne Leslie,Morel Charlotte,Lauzeille Delphine,Belkadi Lorène,Empereur Fabienne,Grosclaude Pascale,Bauvin Eric,Delpierre Cyrille,Lamy Sébastien,Durand Marie-Anne
Abstract
Abstract
Background
With the increase in the number of long-term survivors, interest is shifting from cancer survival to life and quality of life after cancer. These include consequences of long-term side effects of treatment, such as gonadotoxicity. Fertility preservation is becoming increasingly important in cancer management. International recommendations agree on the need to inform patients prior to treatments about the risk of fertility impairment and refer them to specialized centers to discuss fertility preservation. However, the literature reveals suboptimal access to fertility preservation on an international scale, and particularly in France, making information for patients and oncologists a potential lever for action. Our overall goal is to improve access to fertility preservation consultations for women with breast cancer through the development and evaluation of a combined intervention targeting the access and diffusion of information for these patients and brief training for oncologists.
Methods
Firstly, we will improve existing information tools and create brief training content for oncologists using a qualitative, iterative, user-centred and participatory approach (objective 1). We will then use these tools in a combined intervention to conduct a stepped-wedge cluster randomized trial (objective 2) including 750 women aged 18 to 40 newly treated with chemotherapy for breast cancer at one of the 6 participating centers. As the primary outcome of the trial will be the access to fertility preservation counselling before and after using the combined intervention (brochures and brief training for oncologists), we will compare the rate of fertility preservation consultations between the usual care and intervention phases using linear regression models. Finally, we will analyse our approach using a context-sensitive implementation analysis and provide key elements for transferability to other contexts in France (objective 3).
Discussion
We expect to observe an increase in access to fertility preservation consultations as a result of the combined intervention. Particular attention will be paid to the effect of this intervention on socially disadvantaged women, who are known to be at greater risk of inappropriate treatment. The user-centred design principles and participatory approaches used to optimize the acceptability, usability and feasibility of the combined intervention will likely enhance its impact, diffusion and sustainability.
Trial registration
Registry: ClinicalTrials.gov. Trial registration number: NCT05989776. Date of registration: 7th September 2023. URL: https://classic.clinicaltrials.gov/ct2/show/NCT05989776.
Protocol version
Manuscript based on study protocol version 2.0, 21st may 2023.
Funder
Institut National Du Cancer
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet mars. 2018;391(10125):1023–75.
2. Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, et al. Épidémiologie descriptive des cancers en France métropolitaine: incidence, survie et prévalence. Bull Du Cancer Juill. 2019;106(7–8):617–34.
3. Di Emidio G, D’Aurora M, Placidi M, Franchi S, Rossi G, Stuppia L, et al. Pre-conceptional maternal exposure to cyclophosphamide results in modifications of DNA methylation in F1 and F2 mouse oocytes: evidence for transgenerational effects. Epigenetics 2 nov. 2019;14(11):1057–64.
4. Hoog-Labouret N, Merlet F. Conséquences des traitements des cancers et préservation de la fertilité: État Des Connaissances et propositions Rapport De l’Institut national Du cancer et de l’Agence de la biomédecine. Oncologie Mai. 2013;15(5):263–70.
5. Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 15 mars. 2012;118(6):1710–7.